Document is current

Article History

Received: 4 June 2018

Accepted: 13 November 2018

First Online: 4 December 2018

Ethics approval and consent to participate

: PK studies in animals were approved by the Institutional Animal Care and Use Committee (IACUC) of the institution performing the study. Mouse studies were conducted at Emory University (IACUC # 2003021). Prairie dog PK studies were performed at Centers for Disease Control and Prevention, Atlanta (IACUC # 2450SALPRAC). PK studies in guinea pigs were conducted at University of Cincinnati (IACUC # 13–09–03-01).

: Not applicable

: CS is a member of the editorial board (Section Editor) of this journal. The authors declare that they have no competing interests. This work was performed under contract HDTRA112C0051 from the Defense Threat Reduction Agency, DoD to Inhibikase Therapeutics. The principal investigator under the contract was Dr. Milton H. Werner who is also the Chief Executive and Chief Scientific Officer of Inhibikase Therapeutics, Inc. Dr. Werner is a substantial shareholder in Inhibikase Therapeutics. The funds provided to the University of Cincinnati under this contract were the sole source of funds to the University provided by Inhibikase Therapeutics. Dr. Werner was actively involved in the design of the study and the interpretation of the data, but was not a principal author of the manuscript.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.